IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

盘前交易 03-10 05:16:24 EDT

1.77

+0.05

+2.91%

最高1.89	最低1.70	成交量4.65万
今开1.72	昨收1.72	日振幅11.05%
总市值1,728万	流通市值1,620万	总股本976.14万
成交额8.25万	换手率0.51%	流通股本915.07万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.77,"timestamp":1773086400000,"preClose":1.72,"halted":0,"volume":46529,"delay":0,"changeRate":0.029069767441860492,"floatShares":9150700,"shares":9761425,"eps":-6.36096,"marketStatus":"盘前交易","change":0.05,"latestTime":"03-10 05:16:24 EDT","open":1.72,"high":1.89,"low":1.7,"amount":82476.002588,"amplitude":0.110465,"askPrice":1.85,"askSize":42,"bidPrice":1.65,"bidSize":76,"shortable":3,"etf":0,"ttmEps":-6.36096,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773149400000},"marketStatusCode":1,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.81,"postHourTrading":{"tag":"盘后","latestPrice":1.77,"preClose":1.77,"latestTime":"16:42 EDT","volume":72,"amount":122.51,"timestamp":1773088977429,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.2381978401386515},"requestUrl":"/m/hq/s/INAB","defaultTab":"news","newsList":[{"id":"2610181992","title":"In8Bio, Inc.盘中异动 临近收盘快速上涨5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610181992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610181992?lang=zh_cn&edition=full","pubTime":"2026-02-12 04:56","pubTimestamp":1770843381,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日04时56分，In8Bio, Inc.股票出现异动，股价快速拉升5.76%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212045621a4995163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212045621a4995163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2609544426","title":"In8Bio, Inc.盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609544426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609544426?lang=zh_cn&edition=full","pubTime":"2026-02-07 03:34","pubTimestamp":1770406464,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日03时34分，In8Bio, Inc.股票出现波动，股价大幅拉升5.26%。截至发稿，该股报2.00美元/股，成交量2.5425万股，换手率0.26%，振幅7.89%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207033424a6dcb564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207033424a6dcb564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2607566727","title":"In8Bio, Inc.盘中异动 股价大跌5.31%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607566727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607566727?lang=zh_cn&edition=full","pubTime":"2026-01-29 04:59","pubTimestamp":1769633997,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日04时59分，In8Bio, Inc.股票出现波动，股价急速下跌5.31%。截至发稿，该股报1.96美元/股，成交量6.3897万股，换手率0.65%，振幅9.18%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129045957a461a5ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129045957a461a5ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"1149514367","title":"IN8bio宣布私募融资定价，金额高达4020万美元，以推进新型伽马-δ T细胞连接剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1149514367","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149514367?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:01","pubTimestamp":1766149270,"startTime":"0","endTime":"0","summary":"IN8bio宣布私募融资定价，金额高达4020万美元，以推进新型伽马-δ T细胞连接剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2592253907","title":"In8Bio, Inc.盘中异动 下午盘急速跳水5.00%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592253907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592253907?lang=zh_cn&edition=full","pubTime":"2025-12-18 04:05","pubTimestamp":1766001918,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日04时05分，In8Bio, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报1.43美元/股，成交量1.3949万股，换手率0.30%，振幅4.00%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218040518a45825ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218040518a45825ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2584998908","title":"In8Bio, Inc.盘中异动 早盘急速上涨5.01%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584998908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584998908?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:43","pubTimestamp":1763477032,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时43分，In8Bio, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报1.67美元/股，成交量7252股，换手率0.16%，振幅2.77%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224352a7022984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224352a7022984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2572681595","title":"In8Bio, Inc.盘中异动 早盘快速上涨7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572681595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572681595?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:35","pubTimestamp":1759498504,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时35分，In8Bio, Inc.股票出现波动，股价快速上涨7.77%。截至发稿，该股报2.47美元/股，成交量4389股，换手率0.10%，振幅7.77%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213504a4526548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213504a4526548&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2569057794","title":"In8Bio, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569057794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569057794?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:26","pubTimestamp":1758551181,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日22时26分，In8Bio, Inc.股票出现异动，股价急速拉升5.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922222621a72f9c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922222621a72f9c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2518227447","title":"In8Bio, Inc.盘中异动 早盘大幅拉升6.16%报0.262美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227447?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，In8Bio, Inc.股票出现异动，股价快速拉升6.16%。截至发稿，该股报0.262美元/股，成交量9.8859万股，换手率0.14%，振幅0.12%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2517923787","title":"In8Bio, Inc.盘中异动 下午盘急速上涨5.06%报0.272美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923787?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:13","pubTimestamp":1741202030,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时13分，In8Bio, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报0.272美元/股，成交量95.0162万股，换手率1.31%，振幅9.66%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2516677326","title":"In8Bio, Inc.盘中异动 大幅下挫5.77%报0.245美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677326?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，In8Bio, Inc.股票出现异动，股价快速下挫5.77%。截至发稿，该股报0.245美元/股，成交量15.6197万股，换手率0.22%，振幅1.62%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2516232634","title":"In8Bio, Inc.盘中异动 早盘大幅拉升5.65%报0.284美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516232634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516232634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:43","pubTimestamp":1741013001,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时43分，In8Bio, Inc.股票出现波动，股价急速上涨5.65%。截至发稿，该股报0.284美元/股，成交量33.8984万股，换手率0.47%，振幅6.84%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224322a25d434a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224322a25d434a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2516306298","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516306298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516306298?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:20","pubTimestamp":1740774007,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时20分，In8Bio, Inc.股票出现异动，股价快速上涨5.21%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010420079896c2c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010420079896c2c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2514331559","title":"In8Bio, Inc.盘中异动 快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514331559?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:22","pubTimestamp":1740684149,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时22分，In8Bio, Inc.股票出现波动，股价急速跳水5.25%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032230a256bb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032230a256bb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2514863046","title":"In8Bio, Inc.盘中异动 快速拉升6.19%报0.271美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863046?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:32","pubTimestamp":1740591173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时32分，In8Bio, Inc.股票出现异动，股价快速上涨6.19%。截至发稿，该股报0.271美元/股，成交量58.9105万股，换手率0.81%，振幅6.62%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227013253a255212a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227013253a255212a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2514011282","title":"In8Bio, Inc.盘中异动 早盘大幅下挫5.00%报0.258美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011282?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:15","pubTimestamp":1740500131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时15分，In8Bio, Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报0.258美元/股，成交量72.7994万股，换手率1.00%，振幅6.51%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001531abdc9727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001531abdc9727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2514777608","title":"In8Bio, Inc.盘中异动 急速拉升5.49%报0.286美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514777608?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:47","pubTimestamp":1740422820,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时47分，In8Bio, Inc.股票出现波动，股价急速拉升5.49%。截至发稿，该股报0.286美元/股，成交量112.362万股，换手率1.55%，振幅7.15%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024701abdb4536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225024701abdb4536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2513870215","title":"In8Bio, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513870215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513870215?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:47","pubTimestamp":1740160026,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时47分，In8Bio, Inc.股票出现波动，股价快速下跌5.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222014707988e096e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222014707988e096e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2512200484","title":"In8Bio, Inc.盘中异动 临近午盘快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512200484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512200484?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:38","pubTimestamp":1739983110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时38分，In8Bio, Inc.股票出现波动，股价急速拉升5.96%。截至发稿，该股报0.283美元/股，成交量183.947万股，换手率2.54%，振幅9.06%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003831988b45ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003831988b45ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2512166752","title":"In8Bio, Inc.盘中异动 大幅跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166752?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，In8Bio, Inc.股票出现异动，股价急速下跌5.33%。截至发稿，该股报0.275美元/股，成交量104.3万股，换手率1.44%，振幅3.71%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822325396279756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822325396279756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":0.0412},{"period":"1month","weight":-0.1106},{"period":"3month","weight":0.0291},{"period":"6month","weight":-0.0733},{"period":"1year","weight":-0.761},{"period":"ytd","weight":-0.2436}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于发现、开发和商业化用于实体和液体肿瘤的gamma-delta T细胞候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.091988},{"month":2,"riseRate":0.4,"avgChangeRate":-0.06371},{"month":3,"riseRate":0.4,"avgChangeRate":-0.127272},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068431},{"month":5,"riseRate":0.5,"avgChangeRate":0.261664},{"month":6,"riseRate":0.25,"avgChangeRate":-0.322353},{"month":7,"riseRate":0.5,"avgChangeRate":-0.024632},{"month":8,"riseRate":0.4,"avgChangeRate":-0.149237},{"month":9,"riseRate":0.2,"avgChangeRate":-0.145486},{"month":10,"riseRate":0.4,"avgChangeRate":-0.009603},{"month":11,"riseRate":0.4,"avgChangeRate":-0.077155},{"month":12,"riseRate":0.6,"avgChangeRate":0.153062}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}